Infectious Disease Therapeutics Market Size, Share, Growth Report 2032

The global infectious disease therapeutics market size was worth around USD 118.75 billion in 2023 and is predicted to grow to around USD 173.00 billion by 2032 with a compound annual growth rate (CAGR) of roughly 4.27% between 2024 and 2032.  Global healthcare organizations continue to prioritize the fight against infectious diseases, which calls for ongoing research and development of new treatments. In this comprehensive report, of the infectious disease therapeutics market, analyzing its size, share, growth drivers, and future projections up to the year 2032.

Request Free Sample

Global Infectious Disease Therapeutics Market: Overview

Infectious diseases are caused by various pathogenic organisms like parasites, viruses, and bacteria. Such diseases are transmitted from one individual to another via direct or indirect contact. Anti-infective drugs slow or stop the growth of pathogenic microorganisms in the human body. This drug works according to a mechanism of the host defensive system in which the drug directly targets the causative agent. Different infectious diseases like influenza, hepatitis A, malaria, HIV, and hepatitis C cause millions of deaths across the world. These diseases are caused due to inadequate personal hygiene or poor sanitation. Anti-infective drugs prevent the growth of causing agents. Some of the anti-infective drugs that are used for the treatment of infectious diseases are antiviral, anti-parasitic, antifungal, and antibacterial drugs.

Global Infectious Disease Therapeutics Market: Growth Factors

One of the major factors driving the growth of the global infectious disease therapeutics market is the growing prevalence of infectious diseases along with surging initiatives for creating awareness regarding the diagnosis and treatment of such conditions so that early treatment can be given to the patients. The rising clinical trials for the development of new drugs are likely to positively shape the trajectory of the global infectious disease therapeutics market during the forecast period. Moreover, the market is expected to see the patent expiry of many available drugs. The expiry of patents leads to a reduction in the price of these drugs as they now became generic drugs instead of branded drugs. Physicians prescribe these cost-effective drugs to patients so that all classes of people are able to afford such medicines. Positive reimbursement policies that cover the treatments and diagnosis of infectious diseases are anticipated to bolster the growth of the market significantly during the forecast period.

Request Free Sample

Global Infectious Disease Therapeutics Market: Segmentation

The global infectious disease therapeutics market can be segmented into disease, treatment, end-user, and region.

By disease, the market can be segmented into hepatitis, malaria, TB, influenza, HIV, and others. The HIV segment accounts for the largest share in the global infectious disease therapeutics market owing to the rising prevalence of HIV coupled with growing investments to develop effective drugs to treat it.

By treatment, the market can be segmented into anti-parasitic drugs, antiviral drugs, antifungal drugs, antibacterial drugs, and others. The antibacterial drug segment holds the largest share of the global infectious disease therapeutics market.

By end-user, the market can be segmented into hospitals & clinics, retail pharmacies, research organizations, and others.

Infectious Disease Therapeutics Market: Report Scope

Global Infectious Disease Therapeutics Market: Regional Analysis

North America accounts for the largest share of the global infectious disease therapeutics market due to the growing number of favorable reimbursement policies coupled with the increasing prevalence of infectious diseases in the region. Moreover, the presence of prominent market players in the region and the rising number of clinical trials to develop new & effective drugs further propels the growth of the regional market. The increasing funding to boost the research and development for the development of new drugs is likely to bolster the growth of the regional market during the forecast period.

Asia Pacific is expected to grow significantly during the forecast period owing to the high prevalence of infectious diseases like tuberculosis, malaria, HIV, and others. The growing expense of the treatment and diagnosis of infectious diseases is further expected to boost the growth of the regional market. The growing attention of the government in developing countries for the prevention of infectious diseases by raising funds to develop more effective drugs for the treatment of these diseases is likely to propel the growth of the regional market during the forecast period.

Global Infectious Disease Therapeutics Market: Competitive Players

• Boehringer Ingelheim GmbH
• Merck & Co. Inc.
• BioCryst Pharmaceuticals Inc.
• F. Hoffmann-La Roche Ltd.
• Janssen Pharmaceutical Inc.
• GlaxoSmithKline plc
• Gilead
• Novartis AG
• Sanofi
• Pfizer Inc.
• AstraZeneca.
• Others

Global Infectious Disease Therapeutics Market: Segment Analysis

By Disease

• Hepatitis
• Malaria
• TB
• Influenza
• HIV
• Others

By Treatment

• Anti-Parasitic Drugs
• Antiviral Drugs
• Antifungal Drugs
• Antibacterial Drugs
• Others

By End-User

• Hospitals & Clinics
• Retail Pharmacies
• Research Organizations
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of the Middle East & Africa

What Reports Provide

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, ongoing, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.